Literature DB >> 21726228

Canine tonsillar squamous cell carcinoma -- a multi-centre retrospective review of 44 clinical cases.

A Mas1, L Blackwood, P Cripps, S Murphy, J De Vos, N Dervisis, M Martano, G A Polton.   

Abstract

OBJECTIVES: To review the presenting clinical signs, treatment and survival of dogs with tonsillar squamous cell carcinoma and, if possible, to identify useful prognostic indicators.
METHODS: Medical records of 44 dogs were reviewed retrospectively. Clinical signs, clinical stage, time of diagnosis, treatment and outcome were recorded. Data were analysed using the Kaplan-Meier, log-rank, Student's t test, Kruskal-Wallis test and Chi-square/Fisher Exact test as appropriate.
RESULTS: The most frequent clinical signs were cough (12 dogs, 27%), enlarged lymph nodes (11 dogs, 25%) and dysphagia (11 dogs, 25%). Anorexia and lethargy were less common but were significantly associated with a poor outcome. No matter what treatment modalities were used, survival times were short and median survival time for all the dogs in the study was 179 days. However, there were a small number of long-term survivors. CLINICAL SIGNIFICANCE: Dogs with tonsillar squamous cell carcinoma that suffered anorexia and lethargy had shorter survival times than patients without these clinical signs. Although surgery, chemotherapy and radiotherapy seem to increase the median survival time of dogs diagnosed with tonsillar squamous cell carcinoma, there is no highly effective treatment for canine tonsillar squamous cell carcinoma.
© 2011 British Small Animal Veterinary Association.

Entities:  

Mesh:

Year:  2011        PMID: 21726228     DOI: 10.1111/j.1748-5827.2011.01075.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  9 in total

1.  Occult tonsillar squamous cell carcinoma in 2 dogs presenting for treatment of primary oral squamous cell carcinoma.

Authors:  Nicholas J Rancilio; Christopher M Fulkerson
Journal:  Can Vet J       Date:  2018-10       Impact factor: 1.008

2.  Immunohistochemical expression of vascular endothelial growth factor in canine oral squamous cell carcinomas.

Authors:  Manuela Martano; Brunella Restucci; Dora Maria Ceccarelli; Lorenzo Lo Muzio; Paola Maiolino
Journal:  Oncol Lett       Date:  2015-10-30       Impact factor: 2.967

Review 3.  Non-murine models to investigate tumor-immune interactions in head and neck cancer.

Authors:  Carlos Rossa; Nisha J D'Silva
Journal:  Oncogene       Date:  2019-03-14       Impact factor: 9.867

4.  PDPN Is Expressed in Various Types of Canine Tumors and Its Silencing Induces Apoptosis and Cell Cycle Arrest in Canine Malignant Melanoma.

Authors:  Masahiro Shinada; Daiki Kato; Satoshi Kamoto; Sho Yoshimoto; Masaya Tsuboi; Ryohei Yoshitake; Shotaro Eto; Namiko Ikeda; Kohei Saeki; Yuko Hashimoto; Yosuke Takahashi; James Chambers; Kazuyuki Uchida; Mika K Kaneko; Naoki Fujita; Ryohei Nishimura; Yukinari Kato; Takayuki Nakagawa
Journal:  Cells       Date:  2020-05-05       Impact factor: 6.600

5.  Imaging evaluation of dogs and cats with Dysphagia.

Authors:  Rachel E Pollard
Journal:  ISRN Vet Sci       Date:  2012-10-31

6.  p16 Immunostaining of Canine Squamous Cell Carcinomas Is Not Associated with Papillomaviral DNA.

Authors:  Silvia Sabattini; Federica Savini; Laura Gallina; Alessandra Scagliarini; Patrizia Bassi; Giuliano Bettini
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

7.  Complete Resolution of a Recurrent Canine Anal Sac Squamous Cell Carcinoma with Palliative Radiotherapy and Carboplatin Chemotherapy.

Authors:  Antonio Giuliano; Jane Dobson; Sarah Mason
Journal:  Vet Sci       Date:  2017-09-14

8.  CLINICAL AND MAGNETIC RESONANCE IMAGING FEATURES OF INFLAMMATORY VERSUS NEOPLASTIC MEDIAL RETROPHARYNGEAL LYMPH NODE MASS LESIONS IN DOGS AND CATS.

Authors:  Philippa J Johnson; Richard Elders; Pascaline Pey; Ruth Dennis
Journal:  Vet Radiol Ultrasound       Date:  2015-09-07       Impact factor: 1.363

9.  Long-term survival in a cat with tonsillar squamous cell carcinoma treated with surgery and chemotherapy.

Authors:  Elisabetta Treggiari; Giorgio Romanelli; Silvia Ferro; Paola Roccabianca
Journal:  JFMS Open Rep       Date:  2021-02-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.